Skip to content

Indirect pulp capping of deep carious lesions with two pulp capping materials - A Clinical Study

Comparative Evaluation of the Efficacy of Resin Modified Glass Ionomer Cement and Light Curable Tricalcium Silicate Cement as Indirect pulp capping materials in deep carious lesions - A Double Blind Randomized Study.

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/02/017828
Enrollment
46
Registered
2019-02-26
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K040- Pulpitis

Interventions

Intervention1: Resin modified glass ionomer cement (RMGIC) and Light Curable Tricalcium Silicate Cement (TheraCal): The intervention agents will be placed on the pulpal floor or axial wall of the toot

Sponsors

MGM Dental College and Hospital
Lead Sponsor
Dr Vanitha Shenoy
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1. Human permanent 1st and 2nd maxillary and mandibular molars with mature apex. 2. Teeth with Class I or Class II carious lesions with good restorative prognosis. 3. Caries lesion involving inner two third of dentin as visualized on radiograph. 4. Clinical symptoms of reversible pulpitis. 5. Participants who experienced a preoperative pain score of less than 40 mm on visual analogue scale. 6. Early response to electric pulp test or thermal stimulation which does not linger. 7. No periapical changes viewed on periapical radiographs. 8. Healthy subjects.

Exclusion criteria

Exclusion criteria: 1. Clinical symptoms of irreversible pulpitis requiring endodontic treatment. 2. Grossly carious teeth with poor restorative prognosis. 3. Presence of fistulas or swelling. 4. Mobile teeth or tenderness to percussion. 5. Delayed or no response to electric pulp test or thermal stimulation. 6. Participants who experienced a preoperative pain score of more than 40 mm onvisual analogue scale. 7. Participants younger than 18 year of age and older than 40 years of age. 8. Participants who have taken analgesics in the past 24 hours. 9. Presence of periapical pathosis. 10. Participants with systemic health conditions.

Design outcomes

Primary

MeasureTime frame
1. Absence of pain on percussion, post treatment swelling, positive or negative response to cold test and electric pulp test, absence of adverse radiographic findings at time interval of 24 hours, 3 weeks, 3 months and 6 months.Timepoint: Outcomes will be assessed at time period of 24 hours, 3 weeks, 3 months and 6 months.

Secondary

MeasureTime frame
Not applicableTimepoint: Not applicable

Countries

India

Contacts

Public ContactDr Vanitha Shenoy

MGM Dental College and Hospital

shreyalndeshmukh@gmail.com9619496542

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026